- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
U.S. Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Results
3
0 new
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
3 companies
Medpace Holdings
Market Cap: US$8.6b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$293.81
7D
-0.7%
1Y
-24.3%
Alkermes
Market Cap: US$4.9b
A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
ALKS
US$29.90
7D
-2.1%
1Y
28.4%
Niagen Bioscience
Market Cap: US$836.7m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$10.98
7D
8.4%
1Y
282.6%